User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 12 results.
    • Journal article
    Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
    Ribrag, V. Tilly, H. Casasnovas, O. Bosly, André[UCL] Bouabdallah, R. Delarue, R. Boue, F. Bron, D. Feugier, P. Haioun, C. Offner, F. Coiffier, B. (2013) European Journal of Cancer — Vol. 49, no. 4, p. 904-910 (2013)
    • Journal article
    Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: Results of the prospective multicenter H96 trial by the GELA/SFGM study group
    Morschhauser, F. Brice, P. Fermé, C. Diviné, M. Salles, G. Bouabdallah, R. Sebban, C. Voillat, L. Casasnovas, O. Stamatoullas, A. Bouabdallah, K. André, Marc Jais, J.-P. Cazals-Hatem, D. Gisselbrecht, C. (2008) Journal of Clinical Oncology — Vol. 26, no.36, p. 5980-5987 (2008)
    • Journal article
    High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol
    Brice, P. Simon, D Bouabdallah, R. Belanger, C Haioun, C. Thieblemont, C Tilly, H. Harousseau, JL. Doyen, Chantal Martin, C Brousse, N. Solal-Celigny, P. (2000) Annals of Oncology — Vol. 11, no. 12, p. 1585-1590 (2000)
    • Journal article
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Journal article
    Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy : A multicentric prospective study in forty patients
    Delannoy, André[UCL] Sebban, C. Cony-Makhoul, P Cazin, B. Cordonnier, C. Bouabdallah, R. Cahn, J.Y. Dreyfus, F Sadoun, A. Vernant, J.P. Gay, C. Broustet, A. Michaux, Jean-Louis[UCL] Fière, D. (1997) Leukemia — Vol. 11, no. 9, p. 1429-1434 (1997)
    • Speech
    Long term results of the GELA study, R-CHOP vs. CHOP in elderly patients with diffuse large B-cell lymphoma.
    Coiffier, B. Feugier, P Sebban, C. Bouabdallah, R. Delwail, V Tilly, H. Gisselbrecht, C. Bosly, André[UCL] Salles, G. Reyes, F. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Journal article
    Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission
    Delannoy, A. Cazin, B. Thomas, X. Bouabdallah, R. Boiron, J.M. Huguet, F. Straetmans, N.[UCL] Zérazhi, H. Vernant, J.P. Dombret, H. Bilhou-Nabera, C. Charrin, C. Boucheix, C. Sebban, C. Lhéritier, V. Fière, D. (2002) Leukemia and Lymphoma — Vol. 43, no. 1, p. 75-81 (2002)
    • Journal article
    The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party
    El-Najjar, I. Boumendil, A. Luan, J.J. Bouabdallah, R. Thomson, K. Mohty, M. Colombat, P. Biron, P. Tilly, H. Pfreundschuh, M. Cordonnier, C. Sureda, A. Cahn, J.Y. Vernant, J.P. Gribben, J. Cook, G. Haynes, A.P. Ferrant, Augustin[UCL] Finel, H. Montoto, S. Dreger, P. (2014) Annals of oncology : official journal of the European Society for Medical Oncology / ESMO — Vol. 25, no. 11, p. 2224-2229 (2014)
    • Journal article
    A Controlled-study of Recombinant Human Granulocyte-colony-stimulating Factor in Elderly Patients After Treatment for Acute Myelogenous Leukemia
    Dombret, H. Ferrant, Augustin[UCL] Chastang, C. Fenaux, P. Reiffers, J. Bordessoule, D. Bouabdallah, R. Mandelli, F. Auzanneau, G. Tilly, H. Yver, A. Degos, L. (1995) New England Journal of Medicine — Vol. 332, no. 25, p. 1678-83 (1995)
    • Journal article
    Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe d'Etude des lymphomes de l'adulte
    Feugier, P Van Hoof, A. Sebban, C. Solal-Celigny, P. Bouabdallah, R. Ferme, C Christian, B. Lepage, E. Tilly, H. Morschhauser, F. Gaulard, P. Salles, G. Bosly, André[UCL] Gisselbrecht, C. Reyes, F. Coiffier, B. (2005) Journal of Clinical Oncology — Vol. 23, no. 18, p. 4117-4126 (2005)
    • Journal article
    Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N. Briere, J Gisselbrecht, C. Emile, JF Lederlin, P. Sebban, C. Berger, F. Bosly, André[UCL] Morel, Priscilla[UCL] Tilly, H. Bouabdallah, R. Reyes, F. Gaulard, P. Coiffier, B. (2003) Blood — Vol. 101, no. 11, p. 4279-4284 (2003)
    • Journal article
    T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: A matched-control analysis
    Bouabdallah, R. Mounier, N. Guettier, C. Molina, T Ribrag, V. Thieblemont, C Sonet, Anne Delmer, A. Belhadj, K Gaulard, P. Gisselbrecht, C. Xerri, L (2003) Journal of Clinical Oncology — Vol. 21, no. 7, p. 1271-1277 (2003)